• Eur Rev Med Pharmacol Sci · May 2018

    Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits.

    • Y-J Yu and W Xiong.
    • Department of Emergency, Affiliated Hospital of Weifang Medical University, Weifang, China. xiongwen1216@sina.com.
    • Eur Rev Med Pharmacol Sci. 2018 May 1; 22 (9): 2888-2895.

    ObjectiveTo investigate the curative effect of tirofiban combined with recombinant tissue-plasminogen activator (rt-PA) selective intra-arterial thrombolysis on acute middle cerebral artery occlusion (MCAO).Materials And MethodsA total of 60 adult male Japanese white rabbits weighing 2.5-3.0 kg were selected, and the acute cerebral infarction model was established via autologous thromboembolism of middle cerebral artery. Rabbits were randomly divided into 4 groups: tirofiban group (Ti group, 5 μg/kg, n=15), rt-PA group (rt-PA group, 2 mg/kg, n=15), tirofiban + rt-PA group (Ti + rt-PA group, 3 μg/kg Ti + 1 mg/kg rt-PA, n=15), and control group (Co group, n=15). The vascular recanalization rate of intra-arterial thrombolysis was observed via digital subtraction angiography (DSA), relative apparent diffusion coefficient (rADC) was observed via diffusion-weighted imaging (DWI), and neurologic impairment was observed via modified Bederson's scoring method. Rabbits were executed after 24 h, then the volume of cerebral infarction was measured via triphenyl tetrazolium chloride (TTC) staining, pathological examinations were performed using the optical microscope and electron microscope, and immunohistochemical examination was performed for brain-derived neurotrophic factor (BDNF).ResultsIn Ti + rt-PA group, the vascular recanalization rate was 91.7%, and there was no significant bleeding in pathological examination. The rADC value, neurologic impairment score and cerebral infarction area in Ti + rt-PA group were superior to those in Co group, Ti group and rt-PA group. Immunohistochemical results of BDNF showed that the expression of BDNF in Ti + rt-PA group was increased compared with those in Co group, Ti group and rt-PA group. In Ti group and rt-PA group, there were neuronal degeneration, moderate organelle swelling, moderate mitochondrial swelling, enlarged volume and decreased number of cristae, and rupture and disappearance of some mitochondrial cristae. In Co group, neuronal karyopyknosis, nuclear chromatolysis and disappearance of cellular structure could be seen. Results of electron microscopy showed that the shape of neuronal nuclei in Ti + rt-PA group was basically normal, and there were mild mitochondrial swelling and enlarged volume of cristae.ConclusionsEarly application of tirofiban combined with rt-PA in intra-arterial thrombolysis for ultra-early cerebral ischemia can improve the recanalization rate of cerebral artery. The time of cerebral ischemia and hypoxia is short, and the neuronal ischemia-reperfusion injury is mild, whose thrombolysis effect is better than the single application of tirofiban or rt-PA.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.